Talphera (NASDAQ:TLPH) Stock Price Up 1% – Still a Buy?

Shares of Talphera, Inc. (NASDAQ:TLPH) shot up 1% during trading on Thursday . The company traded as high as $1.03 and last traded at $1.01. 243,363 shares traded hands during trading, a decline of 19% from the average session volume of 299,977 shares. The stock had previously closed at $1.00.

Wall Street Analyst Weigh In

TLPH has been the topic of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Talphera in a research note on Wednesday, October 8th. Wall Street Zen raised Talphera to a “hold” rating in a report on Saturday, November 1st. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $5.00.

Talphera Price Performance

The stock has a market capitalization of $47.08 million, a PE ratio of -2.66 and a beta of 0.30. The company’s 50 day moving average price is $1.18 and its two-hundred day moving average price is $0.92.

Talphera (NASDAQ:TLPH) last announced its quarterly earnings data on Wednesday, November 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.01. Analysts forecast that Talphera, Inc. will post -0.64 earnings per share for the current year.

Hedge Funds Weigh In On Talphera

A number of institutional investors have recently added to or reduced their stakes in TLPH. Nantahala Capital Management LLC grew its holdings in Talphera by 75.3% in the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after buying an additional 1,500,000 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Talphera during the 3rd quarter valued at about $29,000. Rosalind Advisors Inc. boosted its position in shares of Talphera by 118.9% during the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock valued at $3,917,000 after acquiring an additional 2,381,818 shares during the last quarter. AIGH Capital Management LLC purchased a new stake in shares of Talphera in the third quarter valued at about $3,979,000. Finally, Dauntless Investment Group LLC acquired a new stake in Talphera during the third quarter worth about $89,000. Hedge funds and other institutional investors own 37.67% of the company’s stock.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.